P915: EFFICACY AND SAFETY OF DARATUMUMAB MONOTHERAPY IN NEWLY DIAGNOSED PATIENTS WITH STAGE 3B LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK

Detalles Bibliográficos
Autores principales: Kastritis, E., Minnema, M. C., Dimopoulos, M. A., Merlini, G., Theodorakakou, F., Fotiou, D., Huart, A., Belhadj, K., Gkolfinopoulos, S., Manousou, K., Sonneveld, P., Palladini, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430408/
http://dx.doi.org/10.1097/01.HS9.0000846528.55550.9c

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430408/
http://dx.doi.org/10.1097/01.HS9.0000846528.55550.9c

Ejemplares similares